沙利度胺可选择性抑制受刺激的人单核细胞产生肿瘤坏死因子α。
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.
作者信息
Sampaio E P, Sarno E N, Galilly R, Cohn Z A, Kaplan G
机构信息
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, New York 10021.
出版信息
J Exp Med. 1991 Mar 1;173(3):699-703. doi: 10.1084/jem.173.3.699.
Abstract
Thalidomide selectively inhibits the production of human monocyte tumor necrosis factor alpha (TNF-alpha) when these cells are triggered with lipopolysaccharide and other agonists in culture. 40% inhibition occurs at the clinically achievable dose of the drug of 1 micrograms/ml. In contrast, the amount of total protein and individual proteins labeled with [35S]methionine and expressed on SDS-PAGE are not influenced. The amounts of interleukin 1 beta (IL-1 beta), IL-6, and granulocyte/macrophage colony-stimulating factor produced by monocytes remain unaltered. The selectivity of this drug may be useful in determining the role of TNF-alpha in vivo and modulating its toxic effects in a clinical setting.
摘要
当人单核细胞在培养中被脂多糖和其他激动剂触发时，沙利度胺可选择性抑制人单核细胞肿瘤坏死因子α（TNF-α）的产生。在该药物临床可达到的1微克/毫升剂量下，抑制率达40%。相比之下，用[35S]甲硫氨酸标记并在SDS-PAGE上表达的总蛋白和单个蛋白的量不受影响。单核细胞产生的白细胞介素1β（IL-1β）、IL-6和粒细胞/巨噬细胞集落刺激因子的量保持不变。这种药物的选择性可能有助于确定TNF-α在体内的作用，并在临床环境中调节其毒性作用。
相似文献
1
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.沙利度胺可选择性抑制受刺激的人单核细胞产生肿瘤坏死因子α。
J Exp Med. 1991 Mar 1;173(3):699-703. doi: 10.1084/jem.173.3.699.
2
3
ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.抗肿瘤脂质A类似物ONO - 4007仅在预激活状态下诱导人单核细胞产生肿瘤坏死因子-α：ONO - 4007和脂多糖对细胞因子产生的不同影响。
J Pharmacol Exp Ther. 1998 Jan;284(1):189-95.
4
Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines.罗红霉素对外周血单个核细胞增殖及脂多糖诱导的细胞因子产生的影响。
Biol Pharm Bull. 1995 Jun;18(6):876-81. doi: 10.1248/bpb.18.876.
5
Effect of theophylline on the production of interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-8 by human peripheral blood mononuclear cells.茶碱对人外周血单个核细胞白细胞介素-1β、肿瘤坏死因子-α和白细胞介素-8产生的影响。
Biol Pharm Bull. 1995 Oct;18(10):1405-8. doi: 10.1248/bpb.18.1405.
6
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.沙利度胺通过增强信使核糖核酸降解对肿瘤坏死因子α发挥抑制作用。
J Exp Med. 1993 Jun 1;177(6):1675-80. doi: 10.1084/jem.177.6.1675.
7
8
Thalidomide inhibits tumor necrosis factor-alpha production by lipopolysaccharide- and lipoarabinomannan-stimulated human microglial cells.
J Infect Dis. 1995 Oct;172(4):1137-40. doi: 10.1093/infdis/172.4.1137.
9
Effects of human immunodeficiency virus and colony-stimulating factors on the production of interleukin 6 and tumor necrosis factor alpha by monocyte/macrophages.人类免疫缺陷病毒和集落刺激因子对单核细胞/巨噬细胞产生白细胞介素6和肿瘤坏死因子α的影响。
AIDS Res Hum Retroviruses. 1997 Jul 1;13(10):829-39. doi: 10.1089/aid.1997.13.829.
10
Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells.沙利度胺对脂多糖诱导单核细胞合成肿瘤坏死因子-α可能具有激动作用或拮抗作用。
Immunopharmacol Immunotoxicol. 1996 Feb;18(1):59-72. doi: 10.3109/08923979609007110.
引用本文的文献
1
3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat.3-单硫代泊马度胺，一种新型免疫调节性酰亚胺药物（IMiD），可减轻大鼠炎症并缓解缺血性中风。
Geroscience. 2025 Mar 17. doi: 10.1007/s11357-025-01573-1.
2
Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma.基因多态性对多发性骨髓瘤中蛋白酶体抑制剂和免疫调节药物治疗结果的影响
Curr Treat Options Oncol. 2025 Mar;26(3):197-212. doi: 10.1007/s11864-025-01295-8. Epub 2025 Mar 5.
3
Kaposi's sarcoma unmasked by corticosteroids in an advanced HIV patient with tuberculosis immune reconstitution inflammatory syndrome.在一名患有结核病免疫重建炎症综合征的晚期艾滋病患者中，皮质类固醇使卡波西肉瘤显现出来。
Indian J Sex Transm Dis AIDS. 2024 Jul-Dec;45(2):141-143. doi: 10.4103/ijstd.ijstd_8_24. Epub 2024 Dec 13.
4
Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments.通过药物重新定位革新卵巢癌治疗，实现加速且具成本效益的治疗。
Front Oncol. 2025 Jan 14;14:1514120. doi: 10.3389/fonc.2024.1514120. eCollection 2024.
5
Asymmetric Dirhodium-Catalyzed Modification of Immunomodulatory Imide Drugs and Their Biological Assessment.不对称铑催化的免疫调节酰亚胺药物修饰及其生物学评估。
ACS Med Chem Lett. 2024 Aug 23;15(9):1575-1583. doi: 10.1021/acsmedchemlett.4c00297. eCollection 2024 Sep 12.
6
Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries.肿瘤坏死因子-α：变幻莫测的皮肤场景中的盟友和敌人。
Int J Mol Sci. 2024 Jul 16;25(14):7762. doi: 10.3390/ijms25147762.
7
PROTAC-Mediated HDAC7 Protein Degradation Unveils Its Deacetylase-Independent Proinflammatory Function in Macrophages.PROTAC 介导的 HDAC7 蛋白降解揭示了其在巨噬细胞中去乙酰化酶非依赖性的促炎功能。
Adv Sci (Weinh). 2024 Sep;11(36):e2309459. doi: 10.1002/advs.202309459. Epub 2024 Jul 25.
8
Neuroinflammation and Dyskinesia: A Possible Causative Relationship?神经炎症与运动障碍：一种可能的因果关系？
Brain Sci. 2024 May 20;14(5):514. doi: 10.3390/brainsci14050514.
9
Anti-inflammatory effect of thalidomide in an experimental lung donor model of brain death.沙利度胺在脑死亡实验性供肺模型中的抗炎作用。
Sci Rep. 2024 Apr 16;14(1):8796. doi: 10.1038/s41598-024-59267-1.
10
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma.ETV4 依赖性转录可塑性维持 MYC 表达并导致多发性骨髓瘤对 IMiD 耐药。
Blood Cancer Discov. 2024 Jan 8;5(1):56-73. doi: 10.1158/2643-3230.BCD-23-0061.
本文引用的文献
1
The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies.沙利度胺的传奇故事。从神经病变到胚胎病变，附先天性异常病例报告。
N Engl J Med. 1962 Dec 6;267:1184-92 contd. doi: 10.1056/NEJM196212062672305.
2
Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions.
J Am Acad Dermatol. 1982 Sep;7(3):317-23. doi: 10.1016/s0190-9622(82)70118-5.
3
Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens.通过内源性酶己糖胺酶测量细胞数量。在检测淋巴因子和细胞表面抗原中的应用。
J Immunol Methods. 1984 Mar 16;67(2):379-88. doi: 10.1016/0022-1759(84)90477-0.
4
Reactions in leprosy.麻风病中的反应
Lepr Rev. 1969 Apr;40(2):77-81. doi: 10.5935/0305-7518.19690016.
5
Thalidomide--effect on T cell subsets as a possible mechanism of action.沙利度胺——对T细胞亚群的影响作为一种可能的作用机制。
Int J Lepr Other Mycobact Dis. 1985 Jun;53(2):201-5.
6
Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.恶病质素（肿瘤坏死因子）合成的调控：内毒素耐受机制
Science. 1986 May 23;232(4753):977-80. doi: 10.1126/science.3754653.
7
Tumors secreting human TNF/cachectin induce cachexia in mice.分泌人肿瘤坏死因子/恶病质素的肿瘤可在小鼠中诱发恶病质。
Cell. 1987 Aug 14;50(4):555-63. doi: 10.1016/0092-8674(87)90028-6.
8
Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.抗淋巴因子B细胞刺激因子1单克隆抗体对体内多克隆IgE应答的抑制作用
Proc Natl Acad Sci U S A. 1986 Dec;83(24):9675-8. doi: 10.1073/pnas.83.24.9675.
9
Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens.分枝杆菌蛋白抗原对单核细胞释放白细胞介素1的直接刺激作用。
J Immunol. 1986 Jan;136(1):193-6.
10
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者循环中恶病质素/肿瘤坏死因子水平升高。
Am J Med. 1988 Sep;85(3):289-91. doi: 10.1016/0002-9343(88)90576-1.
Zotero 插件